Fig. 12
From: Ginsenosides emerging as both bifunctional drugs and nanocarriers for enhanced antitumor therapies
Copyright © 2021 Springer Nature
In vivo antitumor activity by G-PTX. A Fabrication of ginsenoside-anchored liposome and surface glycosyl of ginposome for active-targeting ability to GLUT1 receptor on the surface of tumors. B The suppressed tumor growth of patient-derived xenograft tumor models treated with G-PTX. C The verification of G-PTX active targeting, G-PTX uptake was reduced via inhibiting GLUT1 by siRNA transfection. D The expression of autophagy-related proteins of HGC-27 cells indicating the reversal of drug resistance. Reprinted with the permission from Ref [27].